We are now Inizio Ignite, the global advisory partner for health and life sciences, encompassing connected expertise across Research Partnership, Putnam, Vynamic, and STEM. Our Putnam strategy consulting team bridges science and strategy to enable confident decision-making and build value for pharma. We partner with leading health and life science companies serving brand & commercial leaders, Medical Affairs, access & pricing, and R&D. Our expertise spans offerings including therapeutic area strategy, data & AI strategy, go-to-market strategy, commercialization & growth, value, pricing & access (VPA) strategy, and evidence generation. Proudly part of Inizio – the market-leading commercialization partner for health and life sciences. From early-stage development to loss of exclusivity, we simplify complexity, unlock value, and make collaboration seamless at every pivotal moment – supporting confident, insight-driven decisions that move innovation forward. Follow Inizio Ignite for insights, perspectives, and what’s next in health and life sciences.
Looking for a particular Putnam employee's phone or email?
The Putnam annual revenue was $2.2 billion in 2026.
Matthew Riordan is the Chief Executive Officer (CEO) of Putnam.
308 people are employed at Putnam.
Putnam is based in Boston, Massachusetts.
The NAICS codes for Putnam are [54161, 5416, 54, 541611, 541].
The SIC codes for Putnam are [87, 874].